These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22959526)

  • 21. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
    Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
    ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities.
    Yang X; Shen J; Jiang L; Li W; Yu M; Pan G; Yan Y; Zhang C; Jia W; Xiao L; Yu H; Chen H; Zheng Y; Yu L; Xie Q; Zhou L; Shao L
    Eur J Med Chem; 2018 Dec; 160():37-48. PubMed ID: 30317024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
    Edink E; Akdemir A; Jansen C; van Elk R; Zuiderveld O; de Kanter FJ; van Muijlwijk-Koezen JE; Smit AB; Leurs R; de Esch IJ
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1448-54. PubMed ID: 22243960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural model for the binding sites of allosterically potentiating ligands on nicotinic acetylcholine receptors.
    Luttmann E; Ludwig J; Höffle-Maas A; Samochocki M; Maelicke A; Fels G
    ChemMedChem; 2009 Nov; 4(11):1874-82. PubMed ID: 19739198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.
    Kombo DC; Bencherif M
    J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening.
    Dey R; Chen L
    J Biomol Struct Dyn; 2011 Apr; 28(5):695-715. PubMed ID: 21294583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain.
    Zhang D; Gullingsrud J; McCammon JA
    J Am Chem Soc; 2006 Mar; 128(9):3019-26. PubMed ID: 16506783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeper.
    Papke RL; Stokes C; Williams DK; Wang J; Horenstein NA
    Neuropharmacology; 2011 Jan; 60(1):159-71. PubMed ID: 20650284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.
    Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA
    J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of Lymnaea stagnalis AChBP complexed with the potent nAChR antagonist DHβE suggests a unique mode of antagonism.
    Shahsavar A; Kastrup JS; Nielsen EØ; Kristensen JL; Gajhede M; Balle T
    PLoS One; 2012; 7(8):e40757. PubMed ID: 22927902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
    Xiao Y; Abdrakhmanova GR; Baydyuk M; Hernandez S; Kellar KJ
    Acta Pharmacol Sin; 2009 Jun; 30(6):842-50. PubMed ID: 19448648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
    Zaveri N; Jiang F; Olsen C; Polgar W; Toll L
    J Med Chem; 2010 Nov; 53(22):8187-91. PubMed ID: 20979364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
    Zwart R; Strotton M; Ching J; Astles PC; Sher E
    Eur J Pharmacol; 2014 Mar; 726():77-86. PubMed ID: 24485886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.
    Molinari EJ; Delbono O; Messi ML; Renganathan M; Arneric SP; Sullivan JP; Gopalakrishnan M
    Eur J Pharmacol; 1998 Apr; 347(1):131-9. PubMed ID: 9650859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
    Talley TT; Olivera BM; Han KH; Christensen SB; Dowell C; Tsigelny I; Ho KY; Taylor P; McIntosh JM
    J Biol Chem; 2006 Aug; 281(34):24678-86. PubMed ID: 16803900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-induced conformational change in the alpha7 nicotinic receptor ligand binding domain.
    Henchman RH; Wang HL; Sine SM; Taylor P; McCammon JA
    Biophys J; 2005 Apr; 88(4):2564-76. PubMed ID: 15665135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.